Global and Japan Angiogenesis Modulators Market Insights, Forecast to 2026

Publisher Name :
Date: 29-Oct-2020
No. of pages: 140
Inquire Before Buying

Angiogenesis Modulators market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Angiogenesis Modulators market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Angiogenesis Modulators market is segmented into

- Angiogenesis Inhibitors

- Angiogenesis Stimulators

- Angiogenin

- Others

Segment by Application, the Angiogenesis Modulators market is segmented into

- Breast Cancer

- Colorectal Cancer

- Lung Cancer

- Prostate Cancer

- Others

Regional and Country-level Analysis

The Angiogenesis Modulators market is analysed and market size information is provided by regions (countries).

The key regions covered in the Angiogenesis Modulators market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Angiogenesis Modulators Market Share Analysis

Angiogenesis Modulators market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Angiogenesis Modulators business, the date to enter into the Angiogenesis Modulators market, Angiogenesis Modulators product introduction, recent developments, etc.

The major vendors covered:

- Celgene Corporation (USA)

- Eisai (Japan)

- Amgen, Inc. (USA)

- Genentech, Inc. (USA)

- GlaxoSmithKline plc (UK)

- Bayer Pharma AG (Germany)

- Bionomics Ltd. (Australia)

- CASI Pharmaceuticals, Inc. (USA)

- AstraZeneca plc (UK)

- Eli Lilly and Company (USA)

- F.Hoffmann-La Roche AG (Switzerland)

Global and Japan Angiogenesis Modulators Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Angiogenesis Modulators Product Introduction
1.2 Market Segments
1.3 Key Angiogenesis Modulators Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Angiogenesis Modulators Market Size Growth Rate by Type
1.4.2 Angiogenesis Inhibitors
1.4.3 Angiogenesis Stimulators
1.4.4 Angiogenin
1.4.5 Others
1.5 Market by Application
1.5.1 Global Angiogenesis Modulators Market Size Growth Rate by Application
1.5.2 Breast Cancer
1.5.3 Colorectal Cancer
1.5.4 Lung Cancer
1.5.5 Prostate Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Angiogenesis Modulators Market Size, Estimates and Forecasts
2.1.1 Global Angiogenesis Modulators Revenue 2015-2026
2.1.2 Global Angiogenesis Modulators Sales 2015-2026
2.2 Global Angiogenesis Modulators, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Angiogenesis Modulators Historical Market Size by Region (2015-2020)
2.3.1 Global Angiogenesis Modulators Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Angiogenesis Modulators Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Angiogenesis Modulators Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Angiogenesis Modulators Sales Forecast by Region (2021-2026)
2.4.2 Global Angiogenesis Modulators Revenue Forecast by Region (2021-2026)
3 Global Angiogenesis Modulators Competitor Landscape by Players
3.1 Global Top Angiogenesis Modulators Sales by Manufacturers
3.1.1 Global Angiogenesis Modulators Sales by Manufacturers (2015-2020)
3.1.2 Global Angiogenesis Modulators Sales Market Share by Manufacturers (2015-2020)
3.2 Global Angiogenesis Modulators Manufacturers by Revenue
3.2.1 Global Angiogenesis Modulators Revenue by Manufacturers (2015-2020)
3.2.2 Global Angiogenesis Modulators Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Angiogenesis Modulators Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Angiogenesis Modulators Revenue in 2019
3.2.5 Global Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Angiogenesis Modulators Price by Manufacturers
3.4 Global Angiogenesis Modulators Manufacturing Base Distribution, Product Types
3.4.1 Angiogenesis Modulators Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Angiogenesis Modulators Product Type
3.4.3 Date of International Manufacturers Enter into Angiogenesis Modulators Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Angiogenesis Modulators Market Size by Type (2015-2020)
4.1.1 Global Angiogenesis Modulators Sales by Type (2015-2020)
4.1.2 Global Angiogenesis Modulators Revenue by Type (2015-2020)
4.1.3 Angiogenesis Modulators Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Angiogenesis Modulators Market Size Forecast by Type (2021-2026)
4.2.1 Global Angiogenesis Modulators Sales Forecast by Type (2021-2026)
4.2.2 Global Angiogenesis Modulators Revenue Forecast by Type (2021-2026)
4.2.3 Angiogenesis Modulators Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Angiogenesis Modulators Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Angiogenesis Modulators Market Size by Application (2015-2020)
5.1.1 Global Angiogenesis Modulators Sales by Application (2015-2020)
5.1.2 Global Angiogenesis Modulators Revenue by Application (2015-2020)
5.1.3 Angiogenesis Modulators Price by Application (2015-2020)
5.2 Angiogenesis Modulators Market Size Forecast by Application (2021-2026)
5.2.1 Global Angiogenesis Modulators Sales Forecast by Application (2021-2026)
5.2.2 Global Angiogenesis Modulators Revenue Forecast by Application (2021-2026)
5.2.3 Global Angiogenesis Modulators Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Angiogenesis Modulators Market Size YoY Growth 2015-2026
6.1.1 Japan Angiogenesis Modulators Sales YoY Growth 2015-2026
6.1.2 Japan Angiogenesis Modulators Revenue YoY Growth 2015-2026
6.1.3 Japan Angiogenesis Modulators Market Share in Global Market 2015-2026
6.2 Japan Angiogenesis Modulators Market Size by Players (International and Local Players)
6.2.1 Japan Top Angiogenesis Modulators Players by Sales (2015-2020)
6.2.2 Japan Top Angiogenesis Modulators Players by Revenue (2015-2020)
6.3 Japan Angiogenesis Modulators Historic Market Review by Type (2015-2020)
6.3.1 Japan Angiogenesis Modulators Sales Market Share by Type (2015-2020)
6.3.2 Japan Angiogenesis Modulators Revenue Market Share by Type (2015-2020)
6.3.3 Japan Angiogenesis Modulators Price by Type (2015-2020)
6.4 Japan Angiogenesis Modulators Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Angiogenesis Modulators Sales Forecast by Type (2021-2026)
6.4.2 Japan Angiogenesis Modulators Revenue Forecast by Type (2021-2026)
6.4.3 Japan Angiogenesis Modulators Price Forecast by Type (2021-2026)
6.5 Japan Angiogenesis Modulators Historic Market Review by Application (2015-2020)
6.5.1 Japan Angiogenesis Modulators Sales Market Share by Application (2015-2020)
6.5.2 Japan Angiogenesis Modulators Revenue Market Share by Application (2015-2020)
6.5.3 Japan Angiogenesis Modulators Price by Application (2015-2020)
6.6 Japan Angiogenesis Modulators Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Angiogenesis Modulators Sales Forecast by Application (2021-2026)
6.6.2 Japan Angiogenesis Modulators Revenue Forecast by Application (2021-2026)
6.6.3 Japan Angiogenesis Modulators Price Forecast by Application (2021-2026)
7 North America
7.1 North America Angiogenesis Modulators Market Size YoY Growth 2015-2026
7.2 North America Angiogenesis Modulators Market Facts & Figures by Country
7.2.1 North America Angiogenesis Modulators Sales by Country (2015-2020)
7.2.2 North America Angiogenesis Modulators Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Angiogenesis Modulators Market Size YoY Growth 2015-2026
8.2 Europe Angiogenesis Modulators Market Facts & Figures by Country
8.2.1 Europe Angiogenesis Modulators Sales by Country
8.2.2 Europe Angiogenesis Modulators Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Angiogenesis Modulators Market Size YoY Growth 2015-2026
9.2 Asia Pacific Angiogenesis Modulators Market Facts & Figures by Country
9.2.1 Asia Pacific Angiogenesis Modulators Sales by Region (2015-2020)
9.2.2 Asia Pacific Angiogenesis Modulators Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Angiogenesis Modulators Market Size YoY Growth 2015-2026
10.2 Latin America Angiogenesis Modulators Market Facts & Figures by Country
10.2.1 Latin America Angiogenesis Modulators Sales by Country
10.2.2 Latin America Angiogenesis Modulators Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Angiogenesis Modulators Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Angiogenesis Modulators Market Facts & Figures by Country
11.2.1 Middle East and Africa Angiogenesis Modulators Sales by Country
11.2.2 Middle East and Africa Angiogenesis Modulators Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Celgene Corporation (USA)
12.1.1 Celgene Corporation (USA) Corporation Information
12.1.2 Celgene Corporation (USA) Description and Business Overview
12.1.3 Celgene Corporation (USA) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Celgene Corporation (USA) Angiogenesis Modulators Products Offered
12.1.5 Celgene Corporation (USA) Recent Development
12.2 Eisai (Japan)
12.2.1 Eisai (Japan) Corporation Information
12.2.2 Eisai (Japan) Description and Business Overview
12.2.3 Eisai (Japan) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Eisai (Japan) Angiogenesis Modulators Products Offered
12.2.5 Eisai (Japan) Recent Development
12.3 Amgen, Inc. (USA)
12.3.1 Amgen, Inc. (USA) Corporation Information
12.3.2 Amgen, Inc. (USA) Description and Business Overview
12.3.3 Amgen, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Amgen, Inc. (USA) Angiogenesis Modulators Products Offered
12.3.5 Amgen, Inc. (USA) Recent Development
12.4 Genentech, Inc. (USA)
12.4.1 Genentech, Inc. (USA) Corporation Information
12.4.2 Genentech, Inc. (USA) Description and Business Overview
12.4.3 Genentech, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Genentech, Inc. (USA) Angiogenesis Modulators Products Offered
12.4.5 Genentech, Inc. (USA) Recent Development
12.5 GlaxoSmithKline plc (UK)
12.5.1 GlaxoSmithKline plc (UK) Corporation Information
12.5.2 GlaxoSmithKline plc (UK) Description and Business Overview
12.5.3 GlaxoSmithKline plc (UK) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline plc (UK) Angiogenesis Modulators Products Offered
12.5.5 GlaxoSmithKline plc (UK) Recent Development
12.6 Bayer Pharma AG (Germany)
12.6.1 Bayer Pharma AG (Germany) Corporation Information
12.6.2 Bayer Pharma AG (Germany) Description and Business Overview
12.6.3 Bayer Pharma AG (Germany) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bayer Pharma AG (Germany) Angiogenesis Modulators Products Offered
12.6.5 Bayer Pharma AG (Germany) Recent Development
12.7 Bionomics Ltd. (Australia)
12.7.1 Bionomics Ltd. (Australia) Corporation Information
12.7.2 Bionomics Ltd. (Australia) Description and Business Overview
12.7.3 Bionomics Ltd. (Australia) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bionomics Ltd. (Australia) Angiogenesis Modulators Products Offered
12.7.5 Bionomics Ltd. (Australia) Recent Development
12.8 CASI Pharmaceuticals, Inc. (USA)
12.8.1 CASI Pharmaceuticals, Inc. (USA) Corporation Information
12.8.2 CASI Pharmaceuticals, Inc. (USA) Description and Business Overview
12.8.3 CASI Pharmaceuticals, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Products Offered
12.8.5 CASI Pharmaceuticals, Inc. (USA) Recent Development
12.9 AstraZeneca plc (UK)
12.9.1 AstraZeneca plc (UK) Corporation Information
12.9.2 AstraZeneca plc (UK) Description and Business Overview
12.9.3 AstraZeneca plc (UK) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 AstraZeneca plc (UK) Angiogenesis Modulators Products Offered
12.9.5 AstraZeneca plc (UK) Recent Development
12.10 Eli Lilly and Company (USA)
12.10.1 Eli Lilly and Company (USA) Corporation Information
12.10.2 Eli Lilly and Company (USA) Description and Business Overview
12.10.3 Eli Lilly and Company (USA) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Eli Lilly and Company (USA) Angiogenesis Modulators Products Offered
12.10.5 Eli Lilly and Company (USA) Recent Development
12.11 Celgene Corporation (USA)
12.11.1 Celgene Corporation (USA) Corporation Information
12.11.2 Celgene Corporation (USA) Description and Business Overview
12.11.3 Celgene Corporation (USA) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Celgene Corporation (USA) Angiogenesis Modulators Products Offered
12.11.5 Celgene Corporation (USA) Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Angiogenesis Modulators Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Angiogenesis Modulators Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Angiogenesis Modulators Market Segments
Table 2. Ranking of Global Top Angiogenesis Modulators Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Angiogenesis Modulators Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Angiogenesis Inhibitors
Table 5. Major Manufacturers of Angiogenesis Stimulators
Table 6. Major Manufacturers of Angiogenin
Table 7. Major Manufacturers of Others
Table 8. Global Angiogenesis Modulators Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Angiogenesis Modulators Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Angiogenesis Modulators Sales by Regions 2015-2020 (K MT)
Table 11. Global Angiogenesis Modulators Sales Market Share by Regions (2015-2020)
Table 12. Global Angiogenesis Modulators Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Angiogenesis Modulators Sales Forecast by Region (2021-2026) (K MT)
Table 14. Global Angiogenesis Modulators Sales by Manufacturers (2015-2020) (K MT)
Table 15. Global Angiogenesis Modulators Sales Share by Manufacturers (2015-2020)
Table 16. Global Angiogenesis Modulators Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Angiogenesis Modulators by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiogenesis Modulators as of 2019)
Table 18. Angiogenesis Modulators Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Angiogenesis Modulators Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Angiogenesis Modulators Price (2015-2020) (USD/MT)
Table 21. Angiogenesis Modulators Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Angiogenesis Modulators Product Type
Table 23. Date of International Manufacturers Enter into Angiogenesis Modulators Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Angiogenesis Modulators Sales by Type (2015-2020) (K MT)
Table 26. Global Angiogenesis Modulators Sales Share by Type (2015-2020)
Table 27. Global Angiogenesis Modulators Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Angiogenesis Modulators Revenue Share by Type (2015-2020)
Table 29. Angiogenesis Modulators Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 30. Global Angiogenesis Modulators Sales Share by Type (2021-2026)
Table 31. Global Angiogenesis Modulators Sales by Application (2015-2020) (K MT)
Table 32. Global Angiogenesis Modulators Sales Share by Application (2015-2020)
Table 33. Global Angiogenesis Modulators Sales Share by Application (2021-2026)
Table 34. Global Angiogenesis Modulators Sales Market Share Forecast by Application (2021-2026)
Table 35. Global Angiogenesis Modulators Revenue by Application (2015-2020) (US$ Million)
Table 36. Global Angiogenesis Modulators Revenue Market Share Forecast by Application (2021-2026)
Table 37. Japan Angiogenesis Modulators Sales (K MT) of Key Companies (2015-2020)
Table 38. Japan Angiogenesis Modulators Sales Share by Company (2015-2020)
Table 39. Japan Angiogenesis Modulators Revenue (US$ Million) by Company (2015-2020)
Table 40. Japan Angiogenesis Modulators Sales (K MT) by Type (2015-2020)
Table 41. Japan Angiogenesis Modulators Sales Share by Type (2015-2020)
Table 42. Japan Angiogenesis Modulators Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. Japan Angiogenesis Modulators Price (K MT) by Type (2015-2020)
Table 44. Japan Angiogenesis Modulators Sales (K MT) by Type (2021-2026)
Table 45. Japan Angiogenesis Modulators Sales Share by Type (2021-2026)
Table 46. Japan Angiogenesis Modulators Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. Japan Angiogenesis Modulators Revenue Share by Type (2021-2026)
Table 48. Japan Angiogenesis Modulators Price (K MT) by Type (2021-2026)
Table 49. Japan Angiogenesis Modulators Sales (K MT) by Application (2015-2020)
Table 50. Japan Angiogenesis Modulators Sales Share by Application (2015-2020)
Table 51. Japan Angiogenesis Modulators Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. Japan Angiogenesis Modulators Sales (K MT) by Application (2021-2026)
Table 53. Japan Angiogenesis Modulators Sales Share by Application (2021-2026)
Table 54. Japan Angiogenesis Modulators Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. Japan Angiogenesis Modulators Revenue Share by Application (2021-2026)
Table 56. North America Angiogenesis Modulators Sales by Country (2015-2020) (K MT)
Table 57. North America Angiogenesis Modulators Sales Market Share by Country (2015-2020)
Table 58. North America Angiogenesis Modulators Revenue by Country (2015-2020) (US$ Million)
Table 59. North America Angiogenesis Modulators Revenue Market Share by Country (2015-2020)
Table 60. Europe Angiogenesis Modulators Sales by Country (2015-2020) (K MT)
Table 61. Europe Angiogenesis Modulators Sales Market Share by Country (2015-2020)
Table 62. Europe Angiogenesis Modulators Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe Angiogenesis Modulators Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific Angiogenesis Modulators Sales by Region (2015-2020) (K MT)
Table 65. Asia Pacific Angiogenesis Modulators Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific Angiogenesis Modulators Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific Angiogenesis Modulators Revenue Market Share by Region (2015-2020)
Table 68. Latin America Angiogenesis Modulators Sales by Country (2015-2020) (K MT)
Table 69. Latin America Angiogenesis Modulators Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa Angiogenesis Modulators Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America Angiogenesis Modulators Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Angiogenesis Modulators Sales by Country (2015-2020) (K MT)
Table 73. Middle East and Africa Angiogenesis Modulators Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Angiogenesis Modulators Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Angiogenesis Modulators Revenue Market Share by Country (2015-2020)
Table 76. Celgene Corporation (USA) Corporation Information
Table 77. Celgene Corporation (USA) Description and Business Overview
Table 78. Celgene Corporation (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Celgene Corporation (USA) Angiogenesis Modulators Product
Table 80. Celgene Corporation (USA) Recent Development
Table 81. Eisai (Japan) Corporation Information
Table 82. Eisai (Japan) Description and Business Overview
Table 83. Eisai (Japan) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Eisai (Japan) Product
Table 85. Eisai (Japan) Recent Development
Table 86. Amgen, Inc. (USA) Corporation Information
Table 87. Amgen, Inc. (USA) Description and Business Overview
Table 88. Amgen, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Amgen, Inc. (USA) Product
Table 90. Amgen, Inc. (USA) Recent Development
Table 91. Genentech, Inc. (USA) Corporation Information
Table 92. Genentech, Inc. (USA) Description and Business Overview
Table 93. Genentech, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Genentech, Inc. (USA) Product
Table 95. Genentech, Inc. (USA) Recent Development
Table 96. GlaxoSmithKline plc (UK) Corporation Information
Table 97. GlaxoSmithKline plc (UK) Description and Business Overview
Table 98. GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. GlaxoSmithKline plc (UK) Product
Table 100. GlaxoSmithKline plc (UK) Recent Development
Table 101. Bayer Pharma AG (Germany) Corporation Information
Table 102. Bayer Pharma AG (Germany) Description and Business Overview
Table 103. Bayer Pharma AG (Germany) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Bayer Pharma AG (Germany) Product
Table 105. Bayer Pharma AG (Germany) Recent Development
Table 106. Bionomics Ltd. (Australia) Corporation Information
Table 107. Bionomics Ltd. (Australia) Description and Business Overview
Table 108. Bionomics Ltd. (Australia) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Bionomics Ltd. (Australia) Product
Table 110. Bionomics Ltd. (Australia) Recent Development
Table 111. CASI Pharmaceuticals, Inc. (USA) Corporation Information
Table 112. CASI Pharmaceuticals, Inc. (USA) Description and Business Overview
Table 113. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. CASI Pharmaceuticals, Inc. (USA) Product
Table 115. CASI Pharmaceuticals, Inc. (USA) Recent Development
Table 116. AstraZeneca plc (UK) Corporation Information
Table 117. AstraZeneca plc (UK) Description and Business Overview
Table 118. AstraZeneca plc (UK) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. AstraZeneca plc (UK) Product
Table 120. AstraZeneca plc (UK) Recent Development
Table 121. Eli Lilly and Company (USA) Corporation Information
Table 122. Eli Lilly and Company (USA) Description and Business Overview
Table 123. Eli Lilly and Company (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Eli Lilly and Company (USA) Product
Table 125. Eli Lilly and Company (USA) Recent Development
Table 126. F.Hoffmann-La Roche AG (Switzerland) Corporation Information
Table 127. F.Hoffmann-La Roche AG (Switzerland) Description and Business Overview
Table 128. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. F.Hoffmann-La Roche AG (Switzerland) Product
Table 130. F.Hoffmann-La Roche AG (Switzerland) Recent Development
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key Angiogenesis Modulators Players
Table 135. Angiogenesis Modulators Customers List
Table 136. Angiogenesis Modulators Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiogenesis Modulators Product Picture
Figure 2. Global Angiogenesis Modulators Sales Market Share by Type in 2020 & 2026
Figure 3. Angiogenesis Inhibitors Product Picture
Figure 4. Angiogenesis Stimulators Product Picture
Figure 5. Angiogenin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Angiogenesis Modulators Sales Market Share by Application in 2020 & 2026
Figure 8. Breast Cancer
Figure 9. Colorectal Cancer
Figure 10. Lung Cancer
Figure 11. Prostate Cancer
Figure 12. Others
Figure 13. Angiogenesis Modulators Report Years Considered
Figure 14. Global Angiogenesis Modulators Market Size 2015-2026 (US$ Million)
Figure 15. Global Angiogenesis Modulators Sales 2015-2026 (K MT)
Figure 16. Global Angiogenesis Modulators Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Angiogenesis Modulators Sales Market Share by Region (2015-2020)
Figure 18. Global Angiogenesis Modulators Sales Market Share by Region in 2019
Figure 19. Global Angiogenesis Modulators Revenue Market Share by Region (2015-2020)
Figure 20. Global Angiogenesis Modulators Revenue Market Share by Region in 2019
Figure 21. Global Angiogenesis Modulators Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Angiogenesis Modulators Revenue in 2019
Figure 23. Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Angiogenesis Modulators Sales Market Share by Type (2015-2020)
Figure 25. Global Angiogenesis Modulators Sales Market Share by Type in 2019
Figure 26. Global Angiogenesis Modulators Revenue Market Share by Type (2015-2020)
Figure 27. Global Angiogenesis Modulators Revenue Market Share by Type in 2019
Figure 28. Global Angiogenesis Modulators Market Share by Price Range (2015-2020)
Figure 29. Global Angiogenesis Modulators Sales Market Share by Application (2015-2020)
Figure 30. Global Angiogenesis Modulators Sales Market Share by Application in 2019
Figure 31. Global Angiogenesis Modulators Revenue Market Share by Application (2015-2020)
Figure 32. Global Angiogenesis Modulators Revenue Market Share by Application in 2019
Figure 33. Japan Angiogenesis Modulators Sales Growth Rate 2015-2026 (K MT)
Figure 34. Japan Angiogenesis Modulators Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. Japan Angiogenesis Modulators Market Share in Global Market 2015-2026
Figure 36. Japan 5 and 10 Largest Angiogenesis Modulators Players Market Share by Revenue in Angiogenesis Modulators in 2019
Figure 37. Japan Angiogenesis Modulators Revenue Share by Type (2015-2020)
Figure 38. Japan Angiogenesis Modulators Revenue Growth Rate by Type in 2015 & 2019
Figure 39. Japan Angiogenesis Modulators Revenue Share by Application (2015-2020)
Figure 40. Japan Angiogenesis Modulators Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America Angiogenesis Modulators Sales Growth Rate 2015-2020 (K MT)
Figure 42. North America Angiogenesis Modulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Angiogenesis Modulators Sales Market Share by Country in 2019
Figure 44. North America Angiogenesis Modulators Revenue Market Share by Country in 2019
Figure 45. U.S. Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 46. U.S. Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 48. Canada Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Angiogenesis Modulators Sales Growth Rate 2015-2020 (K MT)
Figure 50. Europe Angiogenesis Modulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Angiogenesis Modulators Sales Market Share by Country in 2019
Figure 52. Europe Angiogenesis Modulators Revenue Market Share by Country in 2019
Figure 53. Germany Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 54. Germany Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 56. France Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 58. U.K. Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 60. Italy Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 62. Russia Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Angiogenesis Modulators Sales Growth Rate 2015-2020 (K MT)
Figure 64. Asia Pacific Angiogenesis Modulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Angiogenesis Modulators Sales Market Share by Region in 2019
Figure 66. Asia Pacific Angiogenesis Modulators Revenue Market Share by Region in 2019
Figure 67. China Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 68. China Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 70. Japan Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 72. South Korea Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 74. India Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 76. Australia Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 78. Taiwan Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 80. Indonesia Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 82. Thailand Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 84. Malaysia Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 86. Philippines Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 88. Vietnam Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Latin America Angiogenesis Modulators Sales Growth Rate 2015-2020 (K MT)
Figure 90. Latin America Angiogenesis Modulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Angiogenesis Modulators Sales Market Share by Country in 2019
Figure 92. Latin America Angiogenesis Modulators Revenue Market Share by Country in 2019
Figure 93. Mexico Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 94. Mexico Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 96. Brazil Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 98. Argentina Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Middle East and Africa Angiogenesis Modulators Sales Growth Rate 2015-2020 (K MT)
Figure 100. Middle East and Africa Angiogenesis Modulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Angiogenesis Modulators Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Angiogenesis Modulators Revenue Market Share by Country in 2019
Figure 103. Turkey Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 104. Turkey Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Angiogenesis Modulators S
  • (Post-pandemic Era) - Global Non-Gelatin Empty Capsules Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type
    Published: 20-Nov-2020        Price: US 4860 Onwards        Pages: 98
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Non-Gelatin Empty Capsules growth analysis, Competitive Analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main pl......
  • (Post-pandemic Era) - Global Non-Gelatin Empty Capsules Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 20-Nov-2020        Price: US 3620 Onwards        Pages: 116
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Squalane Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 20-Nov-2020        Price: US 3620 Onwards        Pages: 117
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global High Selenium Yeast Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 20-Nov-2020        Price: US 3620 Onwards        Pages: 109
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • Global Activin and Inhibin Market Outlook 2021
    Published: 20-Nov-2020        Price: US 2900 Onwards        Pages: 118
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Activin and Inhibin market is segmented into - Activin - Inhibin Segment by Application -......
  • Global Activin Market Outlook 2021
    Published: 20-Nov-2020        Price: US 2900 Onwards        Pages: 124
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Activin market is segmented into - Activin A Human - Activin-A Mouse/Rat Segment by Application......
  • Global Ox Bezoars (Cow Bezoars) Market Outlook 2021
    Published: 20-Nov-2020        Price: US 2900 Onwards        Pages: 98
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Ox Bezoars (Cow Bezoars) market is segmented into - Natural Bezoar - Artificial Bezoar Segment b......
  • Global Estrogen Market Outlook 2021
    Published: 20-Nov-2020        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Estrogen market is segmented into - Tablets - Injection Segment by Application - Hospital......
  • Global Chinese Patent Medicine Market Outlook 2021
    Published: 20-Nov-2020        Price: US 2900 Onwards        Pages: 116
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Chinese Patent Medicine market is segmented into - Syrup - Liquid - Tablet - Others ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs